OpGen, Inc. (OPGN)
Largest Insider Buys in Sector
OPGN Stock Price History Chart
OPGN Stock Performance
About OpGen, Inc.
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also …
Insider Activity of OpGen, Inc.
Over the last 12 months, insiders at OpGen, Inc. have bought $0 and sold $0 worth of OpGen, Inc. stock.
On average, over the past 5 years, insiders at OpGen, Inc. have bought $4,348.82B and sold $958.16B worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 514,138 shares for transaction amount of $514.14B was made by AEI Capital Ltd (10 percent owner) on 2024‑08‑29.
List of Insider Buy and Sell Transactions, OpGen, Inc.
| 2024-08-29 | 10 percent owner | 514,138 – | $999,998.00 | $514.14B | -7.18% | |||
| 2024-08-27 | 10 percent owner | 564,971 – | $999,999.00 | $564.97B | +2.26% | |||
| 2024-08-16 | 10 percent owner | 3.6M – | $2.72M | $9,808.16B | -20.43% | |||
| 2024-08-13 | 10 percent owner | 566,494 – | $428,724.00 | $242.87B | -12.86% | |||
| 2024-08-08 | Sale | 10 percent owner | 600,000 – | $454,082.00 | $272.45B | -17.71% | ||
| 2024-08-08 | 10 percent owner | 600,000 – | $454,082.00 | $272.45B | -17.71% | |||
| 2024-08-05 | Sale | 10 percent owner | 1.8M – | $913,265.00 | $1,643.88B | -27.91% | ||
| 2024-08-05 | 10 percent owner | 1.8M – | $913,265.00 | $1,643.88B | -27.91% | |||
| 2022-01-26 | Chief Operating Officer | 25,000 0.1497% | $0.85 | $21,250 | -42.69% | |||
| 2021-11-19 | Chief Operating Officer | 10,000 0.1081% | $1.53 | $15,347 | -62.34% | |||
| 2021-11-18 | Chief Executive Officer | 10,000 0.1054% | $1.50 | $14,960 | -59.62% | |||
| 2021-09-15 | Chief Operating Officer | 5,000 0.1081% | $3.07 | $15,350 | -74.95% | |||
| 2021-09-15 | Chief Executive Officer | 5,000 0.1085% | $3.08 | $15,400 | -74.95% | |||
| 2021-06-10 | Chief Operating Officer | 20,000 0.3205% | $2.27 | $45,494 | -38.36% | |||
| 2021-06-10 | Chief Executive Officer | 20,000 0.3149% | $2.24 | $44,701 | -38.36% | |||
| 2020-10-27 | Sale | director | 1,748 0.0289% | $2.35 | $4,108 | +2.23% | ||
| 2020-09-04 | Sale | director | 3,612 0.0557% | $2.19 | $7,910 | +2.25% | ||
| 2020-05-07 | Sale | 10 percent owner | 19 0.0003% | $2.20 | $42 | -3.13% | ||
| 2020-04-23 | Sale | 10 percent owner | 46,612 0.7125% | $2.17 | $101,148 | +0.93% | ||
| 2020-04-22 | Sale | 10 percent owner | 42,375 0.6686% | $2.24 | $94,920 | -1.81% |
Insider Historical Profitability
| jVen Capital, LLC | Chairman and CEO | 5680604 56.4218% | $0.60 | 3 | 0 | |
| ATWOOD BRIAN G | 485925 4.8264% | $0.60 | 1 | 0 | ||
| Versant Ventures III, LLC | 10 percent owner | 483072 4.798% | $0.60 | 1 | 0 | |
| HARRIS & HARRIS GROUP INC /NY/ | 10 percent owner | 330716 3.2848% | $0.60 | 1 | 0 | |
| Ushio Misti | director | 330716 3.2848% | $0.60 | 1 | 0 |